The current study demonstrates novel associations between clinician-derived MCI severity stages and APOE-ε4 status, CSF biomarkers of AD pathology and neurodegeneration, cerebral atrophy in regions vulnerable in AD, and cognitive decline. The gene discussed is APOE; the disease is Mental deterioration.